Search
Experience the words and artwork of three patients who found hope and healing through MSK art programs.
Along with their alluring beauty, minerals — like scientific ideas — open a window onto the history of the world, Dr. Massagué says.
Feelings of guilt are common after surviving cancer, but MSK offers many support services that can help patients feel better.
Dr. Maria Jasin, whose fundamental research on repair of damaged DNA in cells has transformed our understanding of cancers linked to inherited gene mutations, was selected as the 2025 recipient of the Pearl Meister Greengard Prize — the preeminent international award recognizing outstanding women scientists.
Meet Memorial Sloan Kettering senior vice president Cynthia McCollum, who led MSK's response to the COVID-19 pandemic.
New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.
In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.
Memorial Sloan Kettering Cancer Center (MSK) announced that Cardinale Smith, MD, PhD, has joined the institution as the inaugural Chief Medical Officer (CMO).
Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy in patients with head and neck cancers, according to results of an MSK-led clinical trial presented today at the 2025 American Society for Radiation Oncology Annual Meeting.